View Post

Laboratory test aimed at distinguishing breast cancer from benign tumors

In Clinical Studies News by Barbara Jacoby

By: Johns Hopkins University School of Medicine From: A novel laboratory test in development by researchers at the Johns Hopkins Kimmel Cancer Center may be used to help quickly distinguish breast cancer from benign disease. The breast cancer detection assay (BCDA) examines cells from enlarged lymph nodes in the armpit adjacent to a breast and finds chemical markers that …

New hope for hormone resistant breast cancer

In In The News by Barbara Jacoby

From: A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs. Seventy percent of breast cancer patients have oestrogen receptor positive cancer, and most …